InfuSystem Holdings, Inc. (INFU)
$10.1
Rating:
Recommendation:
Buy
| Symbol | INFU |
|---|---|
| Price | $10.1 |
| Beta | 1.260 |
| Volume Avg. | 0.04M |
| Market Cap | 213.953M |
| Shares () | - |
| 52 Week Range | 6.68-11.44 |
| 1y Target Est | - |
| DCF Unlevered | INFU DCF -> | |
|---|---|---|
| DCF Levered | INFU LDCF -> | |
| ROE | 1.84% | Neutral |
| ROA | 0.89% | Neutral |
| Operating Margin | - | |
| Debt / Equity | 70.58% | Buy |
| P/E | 202 | Strong Buy |
| P/B | 4.14 | Strong Buy |
Latest INFU news
About
Download (Excel)InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.